Evidence map›Paper›PMID 39583968›Full record

ArticleFrontiers in endocrinology2024

Vitamin D metabolism-related single nucleotide polymorphisms in Chronic Obstructive Pulmonary Disease risk.

Susana Rojo-Tolosa, Laura Elena Pineda-Lancheros, Andrea Fernández-Alonso, Noelia Márquez-Pete, Yasmin Cura, Cristina Membrive-Jiménez, Luciana Maria Iglecias-Marangoni, MCarmen Ramírez-Tortosa, José María Gálvez-Navas, Cristina Pérez-Ramírez and 2 more

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Susana Rojo-TolosaPneumology Service, University Hospital Virgen de las Nieves, Granada, Spain.
Laura Elena Pineda-LancherosFacultad de Ciencias, Universidad Nacional de Colombia, Bogotá, Colombia.
Andrea Fernández-AlonsoPharmacogenetics Unit, Pharmacy Service, University Hospital Virgen de las Nieves, Granada, Spain.
Noelia Márquez-PetePharmacogenetics Unit, Pharmacy Service, University Hospital Virgen de las Nieves, Granada, Spain.
Yasmin CuraPharmacogenetics Unit, Pharmacy Service, University Hospital Virgen de las Nieves, Granada, Spain.
Cristina Membrive-JiménezPharmacogenetics Unit, Pharmacy Service, University Hospital Virgen de las Nieves, Granada, Spain.
Luciana Maria Iglecias-MarangoniPharmacogenetics Unit, Pharmacy Service, University Hospital Virgen de las Nieves, Granada, Spain.
MCarmen Ramírez-TortosaDepartment of Biochemistry and Molecular Biology II, Faculty of Pharmacy, University of Granada, Granada, Spain.
José María Gálvez-NavasDepartment of Biochemistry and Molecular Biology II, Faculty of Pharmacy, University of Granada, Granada, Spain.
Cristina Pérez-Ramírez *Pharmacogenetics Unit, Pharmacy Service, University Hospital Virgen de las Nieves, Granada, Spain.
Concepción Morales-García *Pneumology Service, University Hospital Virgen de las Nieves, Granada, Spain.
Alberto Jiménez-Morales *Pharmacogenetics Unit, Pharmacy Service, University Hospital Virgen de las Nieves, Granada, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Chronic obstructive pulmonary disease (COPD) is one of the world's major public health problems. It is characterized by a major inflammatory response, where vitamin D, due to its role in regulating the immune system, and genetic variants involved in its metabolism may play an essential role. The aim of this study is to evaluate the association between 13 polymorphisms related to vitamin D metabolism and the COPD risk. Material and methods: A retrospective longitudinal study was designed in which 152 cases of COPD diagnosed at the University Hospital Virgen de las Nieves and 456 controls without the pathology, matched by age and sex, were included. The determination of the 13 polymorphisms was carried out using TaqMan™ probes. Results: Statistical analysis showed that the AA genotype and the A allele of the Conclusions: We can therefore conclude that those variants could be used in the early detection of the disease in the future.

Indexed as

Genetic Predisposition to DiseasePolymorphism, Single NucleotidePulmonary Disease, Chronic ObstructiveVitamin D25-Hydroxyvitamin D3 1-alpha-HydroxylaseAgedCase-Control StudiesFemaleGenotypeHumansLongitudinal StudiesMaleMiddle AgedRetrospective StudiesRisk Factors25-Hydroxyvitamin D3 1-alpha-HydroxylaseCYP27B1 protein, humanVitamin Dbiomarkerschronic obstructive pulmonary diseasemetabolismrisksingle nucleotide polymorphismsvitamin d

Identifiers

PMID39583968
PMCPMC11581940

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.